China policies to promote local production of pharmaceutical products and protect public health

Écrit par © Filactu le . Rubrique: Publications

WHO china policiesFrom the World Health Organization (WHO/OMS) standpoint, the single most important aspect of China’s current policy with respect to the pharmaceutical sector is its close linkage to the objective of universal health care (UHC). UHC is a key priority for the China Government, which has committed to providing access to medicines for its people.

Pharmaceuticals account for a substantial part of the current China health care budget. To achieve and sustain UHC, pharmaceutical supply must be undertaken in a way that is affordable, notwithstanding the fairly substantial financial resources of China. China has a population of approximately 1.4 billion people, and it is a population that is rapidly aging. This will increase demand for pharmaceuticals, and place increasing burden on the health care budget and system as a whole.<

Publication details: Pages: 60, Publication date: 2017, Languages: English, ISBN: 978-92-4-151217-6


Download study: pdf 898kb